Skip to main content

Table 1 Characterization of TAT-TMP-NPs with different dosage

From: TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury

TMP (mg)

Particle

size (nm)

Polydispersity index

Zeta potential

(mV)

Drug loading (%)

Entrapment efficiency (%)

0

79.07 ± 0.36

0.26 ± 0.01

− 28.50 ± 5.16

–

–

10

96.04 ± 2.77

0.25 ± 0.03

− 22.30 ± 0.56

4.70 ± 0.06

40.50 ± 1.28

20

143.27 ± 0.12

0.25 ± 0.02

− 23.27 ± 0.65

4.90 ± 0.51

62.04 ± 0.08

30

163.93 ± 0.38

0.18 ± 0.01

− 26.10 ± 4.55

8.02 ± 0.12

77.27 ± 1.99

40

258.57 ± 2.60

0.41 ± 0.02

− 20.07 ± 1.01

7.33 ± 1.10

75.70 ± 6.01